EATG » Scientific research

Scientific research

ContraVir’s cyclophilin inhibitor CRV431 potently inhibits essential pathway in hepatitis B

First small molecule drug to target critical function of HBx regulatory molecule EDISON, N.J., Dec. 8, 2016 -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV), a biopharmaceutical company focused on the development…

‘Shock and kill’ strategy for curing HIV may endanger patients’ brains

Combination drug treatments have become successful at long-term control of HIV infection, but the goal of totally wiping out the virus and curing patients has so far been stymied by…

Surprising monkey study could lead to ‘functional’ HIV cure

Dr. Anthony Fauci doesn't get too excited about the results of animal studies, and he doesn't make house calls. But when a drug already taken by thousands of people for…

NIH statement on World AIDS Day 2016

Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases Carl W. Dieffenbach, Ph.D., Director, Division of AIDS, NIAID This year, the world marked the 35th anniversary of…

German government announces support for new TB treatments

The government of Germany has announced its support for the development of new treatments to combat tuberculosis (TB). Germany’s Federal Ministry of Education and Research (BMBF) has committed EUR 10…

A new tool to find latent HIV will advance the current treatment strategies

A group of researchers at the Centre for Genomic Regulation (CRG) and the Pompeu Fabra University (UPF) in Barcelona, Spain, have developed a new technology that sheds light on the…

Frontline attack against HIV infection is closer to reality

Adelaide researchers have made significant progress in the development of a potential vaccine to protect against HIV infection. For the first time, researchers have shown that a combined approach –…

Genetically engineered T cells render HIV’s harpoon powerless

Penn team to test "broader, more potent" peptide approach in HIV patients PHILADELPHIA, November 17 — When HIV attacks a T cell, it attaches itself to the cell’s surface and…

New capsule achieves long-term drug delivery

Technology could aid in elimination of malaria and treatment of many other diseases Researchers at MIT and Brigham and Women’s Hospital have developed a new drug capsule that remains in…

Hepatitis C tricks liver cells to sabotage immune defenses

Virus induces liver cells to make molecules that inhibit production of a key immune signaling receptor The virus that causes hepatitis C protects itself by blocking signals that drive elements…